FP7Doctoral network2012–2015

MEDIASRES · Novel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic Reviews

FP7 — People (Marie Curie Actions)

Duration
2012-01-01 → 2015-12-31
EU contribution
€3,935,114
Participants
10
Scheme
MC-ITN

Lines connect the coordinator with its partners.

Results in brief

Novel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic Reviews

MEDIASRES Publishable Summary Final report: 1 January 2012 – 31 December 2015 Marie Curie Initial Training Network GA No. 290025 Scientific Coordinator: Prof. Martin Schumacher Center for Medical Biometry and Medical Informatics University of Freiburg, Germany ms@imbi.uni-freiburg.de or mediasres@imbi.uni-freiburg.de Webpage: www.mediasres-itn.eu Clinical trials, diagnostic and prognostic studies are the primary source of evidence in clinical medicine as well as for developing new therapeutic and diagnostic modalities. Contributions over the last decades have led to state-of-the-art statistical methodology that is now considered standard for designing and analyzing such studies and for synthesis of their results by meta-analytic approaches. However, with the increasing availability of genomic and other molecular techniques, the road seems to be paved towards individualized diagnosis, prognosis, and treatment, usually referred to as personalized medicine. This leads to new challenges for the design and analysis of studies. The corresponding complex structures have to be modelled adequately and results have to be aggregated by corresponding advanced meta-analytic approaches. Novel statistical methodology promises to greatly facilitate development of approaches for personalized medicine. The research area of statistical MEthodology for DIAgnostic/prognostic and therapeutic Studies and systematic REviewS (MEDIASRES) is well suited for early-stage training purposes, as it comprises a wide range of theoretical and applied biostatistical tools that need to be mastered, further developed, and translated into clinical research and practice. MEDIASRES reached the main network goal in establishing a joint research-training programme by an interdisciplinary and intersectorial network (including 3 partners from the private sector) for providing 14 early-stage researchers (ESRs) with deep insight into cutting-edge statistical methodology in order to face current and future challenges in the design and statistical analysis of clinical research. Work performed within the project Scientific research All 14 ESRs have worked extensively on their individual research projects. Major methodological research areas involved longitudinal data, time-to-event data, multistate models, meta-analysis, prediction, regression models for considering genomic or other molecular data, pharmacokinetic/pharmacodynamic modelling, adaptive design and dose finding, non-compliance, missing data and biased sampling. The scientific output has been and will be published in numerous journals (see Dissemination). Training activities MEDIASRES established a fruitful training environment for all ESRs. MEDIASRES provided the ESRs with the breadth and depth of analytical tools and conceptual knowledge needed to address the challenges of modern trial design and data analysis in biostatistics. In total, five face-to-face network-wide training weeks as well as two extensive online courses were conducted in addition to numerous local courses and workshops. Training sessions included basic and specialized statistical courses from a wide range of current topics (epidemiology, meta-analysis, competing risks, Bayesian statistics, causal inference, repeated measurements, multistate models) and practicals (R, ggplot and orgmode) as well as transferable skills courses (such as good scientific practice, scientific, reading, writing and presentation, grant writing, project management and career planning). Transnational research secondments were an essential part of MEDIASRES and complete the picture. Each ESR spent at least 2 months at a Partner Institution whenever possible from academia to industry and vice versa to gain insight into different working environments. One ESR has already obtained her Ph.D., all others are close to submitting or have already submitted their Ph.D. thesis’ and are expected to obtain their Ph.D.s in the first half of 2016. Dissemination • 12 peer-reviewed papers published as per February 25th , 2016. Numerous results are currently submitted or in preparation for publication (> 15 papers). • Results were presented by ESRs at numerous international conferences (> 65 talks and posters). • A symposium with 150 participants was organized in conjunction with the final MEDIASRES Course Week. • The MEDIASRES website is maintained and frequently updated. Deliverables and Milestones All deliverables and milestones of the project were successfully completed. Final results and their potential impact and use The MEDIASRES project contributed substantially to the development of novel methodology for current research questions investigated in diagnostic/prognostic and therapeutic studies. One particular strength of the project is that statistical design and modelling approaches are simultaneously considered on both study and meta-analysis level helping to generalize achieved results. A second particular strength is that the supervisors are internationally recognized biostatisticians from various academic institutions as well as from industry assuring that statistical approaches developed are based on theoretically sound statistical methodology and are fit and well-suited for practical application. The contributions from the MEDIASRES project have received considerable attention on international conferences and in top biostatistical journals. The additional top-level training activities will ensure that fourteen optimally trained young biostatisticians will join the quest for answers to the burning questions in biomedical research.

Data: CORDIS, © European Union

Project objective

Novel statistical methodology promises to greatly facilitate development of approaches for personalised medicine. While state-of-the-art statistical techniques have already advanced clinical trials and diagnostic/prognostic studies as the major source of evidence in clinical medicine, increasing availability of molecular techniques holds an even greater promise. However, for leveraging such information for individualised diagnosis/prognosis, and treatment, the corresponding complex structures have to be adequately modelled and results have to be aggregated by corresponding advanced meta-analytic approaches. The main goal of the project is to establish a joint research-training programme by an interdisciplinary and intersectorial network for providing early-stage researchers with deep insight into cutting-edge statistical methodology. The research area of statistical methodology for diagnostic/prognostic and therapeutic studies and systematic reviews is well suited for early-stage training purposes, as it comprises a wide range of theoretical and applied biostatistical tools that need to be mastered, further developed, and translated into clinical research and practice. Europe-wide exchanges will also be ensured to meet the need for mobility in today’s globalised society. Further career relevant knowledge and skills will be provided through a structured design of education. The early-stage researchers will be trained according to an individually supervised, comprehensive and complementary programme. The structure of these activities is based on the training-through-research approach of the network. The collaboration of leading biostatistical experts will stimulate the discovery of promising statistical methodology useful for the design and analysis of clinical research. The integration of full industry partners and clinical advisors in the network enables optimal conditions for research driven by application, which will ensure tangible benefits of the programme.

Original text from CORDIS.

Participants

  • UNIVERSITAETSKLINIKUM FREIBURG · FreiburgCoordinatorGermany
  • ACADEMISCH ZIEKENHUIS LEIDEN · LeidenNetherlands
  • GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED · LONDONUnited Kingdom
  • H. LUNDBECK AS · ValbyDenmark
  • KOBENHAVNS UNIVERSITET · KOBENHAVNDenmark
  • LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER · LondonUnited Kingdom
  • NOVARTIS PHARMA AG · BaselSwitzerland
  • UNIVERSIDAD DE VIGO · VIGO PONTEVEDRASpain
  • UNIVERSITAET BERN · BernSwitzerland
  • UNIVERSITETET I OSLO · OsloNorway

Links

Data: CORDIS, © European Union